AtomVie Global Radiopharma: Funding, Investors & Team (Sep 2026)
AtomVie Global Radiopharma Inc. ("AtomVie"), established in late 2021, is a leading global Contract Development and Manufacturing Organization (CDMO) specializing in the GMP production and distribution of radiopharmaceuticals for clinical and commercial purposes. It was recently spun out from the Centre for Probe Development and Commercialization (CPDC). AtomVie provides a comprehensive range of scientific, technical, regulatory, quality, logistics, and business support, along with a dedicated infrastructure, to facilitate the development of radiopharmaceuticals from Phase 1 through to the commercial market. With a state-of-the-art facility set to be operational in 2024, AtomVie enables the advancement of radiotherapeutics.
AtomVie Global Radiopharma has raised $90.0M across 1 funding round on record, the most recent a Series A of $90.0M announced in Jun 2023.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
AtomVie Global Radiopharma Company Profile and Key Stats
Latest funding round on record: Jun 2023.
AtomVie Global Radiopharma Funding Rounds
AtomVie Global Radiopharma Founders and Leadership Team
Contact details for the AtomVie Global Radiopharma team: 1 of 1 has an email address on file.
Start 14-day free trial →AtomVie Global Radiopharma Funding Compared to Other Health Care Startups
AtomVie Global Radiopharma's latest round of $90.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AtomVie Global Radiopharma in Health Care and Hamilton
Companies Similar to AtomVie Global Radiopharma
Cuffway develops medical devices for automated, real-time regulation of endotracheal tube cuff pressure to…
Principal Technologies is a Canadian business that invests in healthcare technologies.
Developing Life Altering Treatments for Patients Suffering from Rare Chronic Diseases.
Optimi Health is a supplier of natural, pharmaceutical-grade psilocybin and synthetic psychedelic compounds.…
Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial…
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and…
Canadian Coalition for Seniors' Mental Health works to promote seniors' mental health by connecting people,…
Jack.org is a charitable group that instructs and strengthens young pioneers to change the field of mental…
Aplantex produces plant-based active compounds for application in the pharma, cosmetics, and agri-food…
Perimeter Medical Imaging is a medical technology company driven to transform cancer surgery with ultra-high…
Leveljump Healthcare offers radiology solutions for hospitals, emergency rooms, and private clinics. They…
Psyched Wellness is a Canadian-based company improving the health and wellness of millions with high-quality…
AtomVie Global Radiopharma Funding FAQs
What does AtomVie Global Radiopharma do?
AtomVie Global Radiopharma Inc. ("AtomVie"), established in late 2021, is a leading global Contract Development and Manufacturing Organization (CDMO) specializing in the GMP production and distribution of radiopharmaceuticals for clinical and commercial purposes. It was recently spun out from the Centre for Probe Development and Commercialization (CPDC). AtomVie provides a comprehensive range of scientific, technical, regulatory, quality, logistics, and business support, along with a dedicated infrastructure, to facilitate the development of radiopharmaceuticals from Phase 1 through to the commercial market. With a state-of-the-art facility set to be operational in 2024, AtomVie enables the advancement of radiotherapeutics.
How much funding has AtomVie Global Radiopharma raised?
AtomVie Global Radiopharma has raised $90.0M across 1 round on record. The most recent is a Series A of $90.0M announced in Jun 2023.
When did AtomVie Global Radiopharma last raise funding?
AtomVie Global Radiopharma's most recent funding round on record is a Series A of $90.0M, announced in Jun 2023.
Who founded AtomVie Global Radiopharma?
FundedIQ lists Jayson Ilagan (Founder) at AtomVie Global Radiopharma.
Where is AtomVie Global Radiopharma headquartered?
AtomVie Global Radiopharma is based in Hamilton, Ontario, Canada.
How many employees does AtomVie Global Radiopharma have?
AtomVie Global Radiopharma is in the 51-100 employee band.
How does AtomVie Global Radiopharma's funding compare to other Health Care startups?
AtomVie Global Radiopharma's latest round of $90.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's AtomVie Global Radiopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AtomVie Global Radiopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.